|
SMURF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.838700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.125800E-01 |
| Normal-vs-Stage2 |
8.313800E-02 |
| Normal-vs-Stage3 |
1.80059999999038E-06 |
| Normal-vs-Stage4 |
8.361500E-02 |
| Stage1-vs-Stage2 |
1.669620E-01 |
| Stage1-vs-Stage3 |
1.99087999999126E-05 |
| Stage1-vs-Stage4 |
1.821800E-01 |
| Stage2-vs-Stage3 |
2.287400E-01 |
| Stage2-vs-Stage4 |
7.227600E-01 |
| Stage3-vs-Stage4 |
6.149600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.095100E-03 |
| Normal-vs-AfricanAmerican |
2.551600E-02 |
| Normal-vs-Asian |
6.561400E-03 |
| Caucasian-vs-AfricanAmerican |
5.426200E-01 |
| Caucasian-vs-Asian |
2.085900E-02 |
| AfricanAmerican-vs-Asian |
9.222600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.160400E-03 |
| Normal-vs-Female |
8.052100E-02 |
| Male-vs-Female |
1.810800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.233170E-01 |
| Normal-vs-Age(41-60Yrs) |
9.252100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.475200E-03 |
| Normal-vs-Age(81-100Yrs) |
3.896400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.198200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.518800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.925600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.619750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.162600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.372600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.424900E-03 |
| Normal-vs-Grade 2 |
4.780400E-01 |
| Normal-vs-Grade 3 |
2.21369999999776E-05 |
| Normal-vs-Grade 4 |
8.027800E-02 |
| Grade 1-vs-Grade 2 |
3.789900E-02 |
| Grade 1-vs-Grade 3 |
1.68425999999E-05 |
| Grade 1-vs-Grade 4 |
3.963700E-03 |
| Grade 2-vs-Grade 3 |
3.58489999999767E-05 |
| Grade 2-vs-Grade 4 |
1.409570E-01 |
| Grade 3-vs-Grade 4 |
9.778400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.451200E-01 |
| Normal-vs-ccB subtype |
1.851940E-02 |
| ccA subtype-vs-ccB subtype |
2.033900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.039100E-03 |
| Normal-vs-N1 |
5.644300E-02 |
| N0-vs-N1 |
2.587600E-01 |
|
|
